T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients

Archives of Iranian Medicine

Volumn 15, Issue 2, 2012, Pages 91-94

  Hashemieh, Mozhgan ^a   Azarkeivan, Azita ^b   Akhlaghpoor, Shahram ^c   Shirkavand, Afshan ^d   Sheibani, Kourosh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hemosiderosis; Iron overload; Kidney; Magnetic resonance imaging; Thalassemia

Indexed keywords

FERRITIN;

ADULT; ARTICLE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; THALASSEMIA;

ADOLESCENT; ADULT; BETA-THALASSEMIA; FEMALE; FERRITINS; HEMOSIDEROSIS; HUMANS; IRAN; IRON OVERLOAD; KIDNEY; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; PROSPECTIVE STUDIES;

EID: 84857174704     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Yesilipek MA. Stem cell transplantation in hemoglobinopathies. Hemoglobin. 2007; 31: 251-256.
2. Cunningham M.J, Sankaran VG, Nathan DG, Orkin SH. The thalassaemia syndromes. In: Orkin SH, Nathan DG, Ginsburg D, Fisher DE, Look AT, Lux SE, eds. Nathan and Oski's Hematology of Infancy and Childhood. 7th ed. Philadelphia: Saunders; 2009: 1015-1076.
3. Hamed EA, El Melegy NT. Renal functions in pediatric patients with beta-thalassemia major: Relation to chelation therapy: Original prospective study. Ital J Pediatr. 2010; 36: 39.
4. Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol. 2007; 14: 183-190.
5. Ong-ajyooth L, Malasit P, Ong-ajyooth S, Fucharoen S, Pootrakul P, Vasuvattakul S, et al. Renal function in adult beta-thalassemia/Hb E disease. Nephron. 1998; 78: 156-161.
6. Ponticelli C, Musallam KM, Cianciulli P, Cappellini MD. Renal complications in transfusion-dependent beta thalassaemia. Blood Rev. 2010; 24: 239-244.
7. Koliakos G, Papachristou F, Koussi A, Perifanis V, Tsatra I, Souliou E, et al. Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia. Clin Lab Haematol. 2003; 25: 105-109.
8. Economou M, Printza N, Teli A, Tzimouli V, Tsatra I, Papachristou F, et al. Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox. Acta Haematol. 2010; 123: 148-152.
9. Mastrangelo F, Lopez T, Rizzelli S, Manisco G, Corlianò C, Alfonso L. Function of the kidney in adult patients with Cooley's disease. A preliminary report. Nephron. 1975; 14: 229-236.10.
10. Smolkin V, Halevy R, Levin C, Mines M, Sakran W, Ilia K, et al. Renal function in children with beta-thalassemia major and thalassemia intermedia. Pediatr Nephrol. 2008; 23: 1847-1851.
11. Sadeghi-Bojd S, Hashemi M, Karimi M. Renal tubular function in patients with beta-thalassaemia major in Zahedan, southeast Iran. Singapore Med J. 2008; 49: 410-412.
12. Voskaridou E, Terpos E, Michail S, Hantzi E, Anagnostopoulos A, Margeli A, et al. Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia. Kidney Int. 2006; 69: 2037-2042.
13. Sumboonnanonda A, Malasit P, Tanphaichitr VS, Ong-ajyooth S, Sunthornchart S, Pattanakitsakul S, et al. Renal tubular function in betathalassemia. Pediatr Nephrol. 1998; 12: 280-283.
14. Aldudak B, Karabay Bayazit A, Noyan A, Ozel A, Anarat A, Sasmaz I, et al. Renal function in pediatric patients with beta-thalassemia major. Pediatr Nephrol. 2000; 15: 109-112.
15. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001; 22: 2171-2179.
16. Wood JC, Ghugre N. Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin. 2008; 32: 85-96.
17. Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with beta-thalassaemia major. Pediatr Radiol. 2007; 37: 1191-1200
18. Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM. Principles, techniques, and applications of T2*-based MR imaging and its special applications. Radiographics. 2009; 29: 1433-1449.
19. Schein A, Enriquez C, Coates TD, Wood JC. Magnetic resonance detection of kidney iron deposition in sickle cell disease: A marker of chronic hemolysis. J Magn Reson Imaging. 2008; 28: 698-704.
20. Rossi C, Boss A, Haap M, Martirosian P, Claussen CD, Schick F. Whole-body T2*mapping at 1.5 T. Magn Reson Imaging. 2009; 27: 489-496.